3. 结构
3.1 二维结构
3.2 三维结构
-1
-2
-3
25 26 0 0 0 0 0 0 0999 V2000
-4.5293 0.5921 -1.1733 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.0690 0.4409 1.0458 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7219 -2.0073 -0.1918 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.0537 -0.7824 0.3318 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0621 0.0893 0.1908 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.4364 -0.3922 0.6748 C 0 0 0 0 0 0 0 0 0 0 0 0
2.1632 -0.7043 -0.1376 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3833 -2.0644 0.0901 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.3215 -0.0688 -0.5422 C 0 0 0 0 0 0 0 0 0 0 0 0
1.2416 1.4816 0.3115 C 0 0 0 0 0 0 0 0 0 0 0 0
3.4400 -0.1731 -0.3520 C 0 0 0 0 0 0 0 0 0 0 0 0
2.5129 2.0271 0.0998 C 0 0 0 0 0 0 0 0 0 0 0 0
3.5939 1.2106 -0.2268 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.7091 0.3510 -0.1210 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.9068 -1.1985 1.2542 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.4157 0.4738 1.3494 H 0 0 0 0 0 0 0 0 0 0 0 0
-0.1362 -3.0126 0.0928 H 0 0 0 0 0 0 0 0 0 0 0 0
-1.8776 0.7480 -1.1223 H 0 0 0 0 0 0 0 0 0 0 0 0
-2.4071 -0.9521 -1.1851 H 0 0 0 0 0 0 0 0 0 0 0 0
2.3026 -2.8054 -0.4086 H 0 0 0 0 0 0 0 0 0 0 0 0
0.4096 2.1328 0.5640 H 0 0 0 0 0 0 0 0 0 0 0 0
4.2822 -0.8079 -0.6064 H 0 0 0 0 0 0 0 0 0 0 0 0
2.6571 3.1004 0.1913 H 0 0 0 0 0 0 0 0 0 0 0 0
4.5727 1.6555 -0.3870 H 0 0 0 0 0 0 0 0 0 0 0 0
-5.4301 0.8511 -0.8837 H 0 0 0 0 0 0 0 0 0 0 0 0
1 14 1 0 0 0 0
1 25 1 0 0 0 0
2 14 2 0 0 0 0
3 7 1 0 0 0 0
3 8 1 0 0 0 0
3 20 1 0 0 0 0
4 5 1 0 0 0 0
4 6 1 0 0 0 0
4 8 2 0 0 0 0
5 7 1 0 0 0 0
5 10 2 0 0 0 0
6 9 1 0 0 0 0
6 15 1 0 0 0 0
6 16 1 0 0 0 0
7 11 2 0 0 0 0
8 17 1 0 0 0 0
9 14 1 0 0 0 0
9 18 1 0 0 0 0
9 19 1 0 0 0 0
10 12 1 0 0 0 0
10 21 1 0 0 0 0
11 13 1 0 0 0 0
11 22 1 0 0 0 0
12 13 2 0 0 0 0
12 23 1 0 0 0 0
13 24 1 0 0 0 0
4. 国际命名与标识
4.1 IUPAC Name
3-(1H-indol-3-yl)propanoic acid
4.2 InChl
InChI=1S/C11H11NO2/c13-11(14)6-5-8-7-12-10-4-2-1-3-9(8)10/h1-4,7,12H,5-6H2,(H,13,14)
4.3 InChlKey
GOLXRNDWAUTYKT-UHFFFAOYSA-N
4.4 Canonical SMILES
C1=CC=C2C(=C1)C(=CN2)CCC(=O)O
4.5 lsomeric SMILES
-
4.6 SDF文件
5. 波谱数据
5.1 13C核磁共振谱(13C NMR)
5.2 1H核磁共振谱(1H NMR)
5.3 质谱(MS)
5.4 红外光谱(IR)
5.5 紫外/可见光谱(UV/Vis)
6. 相关药材
7. 相关靶点
8. 相关疾病